PG(16:0/18:1(9Z)) (BioDeep_00000004082)
Main id: BioDeep_00000410800
human metabolite Endogenous blood metabolite
代谢物信息卡片
化学式: C40H77O10P (748.5254072)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)CO
InChI: InChI=1S/C40H77O10P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h17-18,37-38,41-42H,3-16,19-36H2,1-2H3,(H,45,46)/t37-,38+/m0/s1
描述信息
PG(16:0/18:1(9Z)) is a phosphatidylglycerol or glycerophospholipid (PG or GP). It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PG(16:0/18:1(9Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of oleic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phosphatidylglycerol is present at a level of 1-2\\% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant at up to 11\\% of the total. It is well established that the concentration of phosphatidylglycerol increases during fetal development. Phosphatidylglycerol may be present in animal tissues merely as a precursor for diphosphatidylglycerol (cardiolipin). Phosphatidylglycerol is formed from phosphatidic acid by a sequence of enzymatic reactions that proceeds via the intermediate, cytidine diphosphate diacylglycerol (CDP-diacylglycerol). Bioynthesis proceeds by condensation of phosphatidic acid and cytidine triphosphate with elimination of pyrophosphate via the action of phosphatidate cytidyltransferase (or CDP-synthase). CDP-diacylglycerol then reacts with glycerol-3-phosphate via phosphatidylglycerophosphate synthase to form 3-sn-phosphatidyl-1-sn-glycerol 3-phosphoric acid, with the release of cytidine monophosphate (CMP). Finally, phosphatidylglycerol is formed by the action of specific phosphatases. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PGs have a net charge of -1 at physiological pH and are found in high concentration in mitochondrial membranes and as components of pulmonary surfactant. PG also serves as a precursor for the synthesis of cardiolipin. PG is synthesized from CDP-diacylglycerol and glycerol-3-phosphate.
PG(16:0/18:1(9Z)) is a phosphatidylglycerol. Phosphatidylglycerols consist of a glycerol 3-phosphate backbone esterified to either saturated or unsaturated fatty acids on carbons 1 and 2. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PG(16:0/18:1(9Z)), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. In E. coli glycerophospholipid metabolism, phosphatidylglycerol is formed from phosphatidic acid (1,2-diacyl-sn-glycerol 3-phosphate) by a sequence of enzymatic reactions that proceeds via two intermediates, cytidine diphosphate diacylglycerol (CDP-diacylglycerol) and phosphatidylglycerophosphate (PGP, a phosphorylated phosphatidylglycerol). Phosphatidylglycerols, along with CDP-diacylglycerol, also serve as precursor molecules for the synthesis of cardiolipin, a phospholipid found in membranes.
同义名列表
35 个代谢物同义名
[(2S)-2,3-dihydroxypropoxy][(2R)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic acid; (2S)-2,3-dihydroxypropoxy((2R)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propoxy)phosphinic acid; 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1-rac-glycerol); 1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1-glycerol); 1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-sn-glycerol; 1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-glycerol sodium salt; 1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoglycerol; 1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1-sn-glycerol); 1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1’-glycerol); 1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1-glycerol); 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol; Phosphatidylglycerol(16:0/18:1omega9); Phosphatidylglycerol(16:0/18:1(9Z)); Phosphatidylglycerol(16:0/18:1n9); Phosphatidylglycerol(16:0/18:1W9); Phosphatidylglycerol(16:0/18:1); Phosphatidylglycerol(34:1); 1-Palmitoyl-2-oleoyl-GPG; GPG(16:0/18:1OMEGA9); PG(16:0/18:1OMEGA9); GPG(16:0/18:1(9Z)); PG(16:0/18:1(9Z)); GPG(16:0/18:1W9); GPG(16:0/18:1N9); PG(16:0/18:1W9); PG(16:0/18:1N9); GPG(16:0/18:1); PG(16:0/18:1); PG(16:0_18:1); C16:0/18:1 PG; 16:0/18:1 PG; GPG(34:1); PG(34:1); PG 34:1; POPG
数据库引用编号
17 个数据库交叉引用编号
- ChEBI: CHEBI:182018
- ChEBI: CHEBI:34080
- ChEBI: CHEBI:73234
- KEGG: C13883
- PubChem: 52941750
- PubChem: 5283509
- PubChem: 123897
- HMDB: HMDB0010574
- Metlin: METLIN61850
- LipidMAPS: LMGP04010002
- foodb: FDB027724
- chemspider: 24768073
- CAS: 87246-80-8
- PMhub: MS000015433
- PubChem: 854128
- 3DMET: B05667
- NIKKAJI: J778.938F
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
452 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(452)
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/16:1(9Z)/16:0/18:1(9Z)):
CDP-DG(16:0/16:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/16:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(11Z)):
Glycerone phosphate + Hydrogen Ion + NADPH ⟶ Glycerol 3-phosphate + NADP
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(11Z)):
Glycerone phosphate + Hydrogen Ion + NADPH ⟶ Glycerol 3-phosphate + NADP
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/16:0/16:0/18:1(9Z)):
CDP-DG(16:0/16:0) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/16:0)
- phospholipid biosynthesis (CL(19:0cycv8c/16:0/18:1(9Z)/19:0cycv8c)):
CDP-DG(19:1(9Z)/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(19:iso/18:1(9Z))
- phospholipid biosynthesis CL(16:0/17:0cycw7c/17:0cycw7c/18:1(9Z)):
CDP-DG(19:1(9Z)/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(19:iso/18:1(9Z))
- phospholipid biosynthesis CL(16:0/17:0cycw7c/18:1(9Z)/17:0cycw7c):
CDP-DG(19:1(9Z)/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(19:iso/18:1(9Z))
- phospholipid biosynthesis CL(16:0/18:1(9Z)/17:0cycw7c/17:0cycw7c):
CDP-DG(19:1(9Z)/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(19:iso/18:1(9Z))
- phospholipid biosynthesis CL(16:0/18:1(9Z)/19:0cycv8c/19:0cycv8c):
CDP-DG(19:1(9Z)/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:0)
- phospholipid biosynthesis CL(16:0/19:0cycv8c/18:1(9Z)/19:0cycv8c):
CDP-DG(19:1(9Z)/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:0)
- phospholipid biosynthesis CL(16:0/19:0cycv8c/19:0cycv8c/18:1(9Z)):
CDP-DG(19:1(9Z)/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:0)
- phospholipid biosynthesis (CL(18:1(9Z)/15:0cyclo/16:0/18:1(9Z))):
CDP-DG(19:1(9Z)/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(19:iso/18:1(9Z))
- phospholipid biosynthesis CL(16:1(9Z)/17:0cycw7c/17:0cycw7c/18:1(9Z)):
CDP-DG(19:1(9Z)/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(19:iso/18:1(9Z))
- phospholipid biosynthesis CL(17:0cycw7c/16:0/17:0cycw7c/18:1(9Z)):
CDP-DG(19:1(9Z)/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(19:iso/18:1(9Z))
- phospholipid biosynthesis CL(17:0cycw7c/16:0/18:1(9Z)/17:0cycw7c):
CDP-DG(19:1(9Z)/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(19:iso/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/18:1(11Z)):
Glycerone phosphate + Hydrogen Ion + NADPH ⟶ Glycerol 3-phosphate + NADP
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/18:1(9Z)):
Glycerone phosphate + Hydrogen Ion + NADPH ⟶ Glycerol 3-phosphate + NADP
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(9Z)):
Glycerone phosphate + Hydrogen Ion + NADPH ⟶ Glycerol 3-phosphate + NADP
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:0):
Glycerone phosphate + Hydrogen Ion + NADPH ⟶ Glycerol 3-phosphate + NADP
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:1(11Z)):
Glycerone phosphate + Hydrogen Ion + NADPH ⟶ Glycerol 3-phosphate + NADP
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:1(13Z)):
Glycerone phosphate + Hydrogen Ion + NADPH ⟶ Glycerol 3-phosphate + NADP
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z)):
Glycerone phosphate + Hydrogen Ion + NADPH ⟶ Glycerol 3-phosphate + NADP
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:0):
Glycerone phosphate + Hydrogen Ion + NADPH ⟶ Glycerol 3-phosphate + NADP
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:1(11Z)):
Glycerone phosphate + Hydrogen Ion + NADPH ⟶ Glycerol 3-phosphate + NADP
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:1(13Z)):
Glycerone phosphate + Hydrogen Ion + NADPH ⟶ Glycerol 3-phosphate + NADP
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/20:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:1(11Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:1(11Z)/20:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:1(11Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:1(11Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:1(13Z)/20:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:1(13Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:1(13Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:0/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:0/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:1(13Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:3(5Z,8Z,11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:3(5Z,8Z,11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:3(5Z,8Z,11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:3(5Z,8Z,11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:0/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:0):
CDP-DG(18:1(9Z)/16:0) + PG(16:0/18:1(9Z)) ⟶ CL(16:0/18:1(9Z)/18:1(9Z)/16:0) + Cytidine monophosphate
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:1(11Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:2(9Z,12Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:0/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:1(11Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:1(11Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:1(11Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:0/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:0/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Cardiolipin Biosynthesis CL(16:0/18:1(9Z)/22:1(13Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(15:0cycw5/15:0cycw5/16:0/18:1(9Z)):
CDP-DG(15:0cycw5/15:0cycw5) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(15:0cycw5/15:0cycw5)
- Phospholipid Biosynthesis CL(15:0cycw5/16:0/16:0/18:1(9Z)):
CDP-DG(15:0cycw5/16:0) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(15:0cycw5/16:0)
- Phospholipid Biosynthesis CL(15:0cycw5/18:1(9Z)/16:0/18:1(9Z)):
CDP-DG(15:0cycw5/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(15:0cycw5/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/15:0cycw5/16:0/18:1(9Z)):
CDP-DG(16:0/15:0cycw5) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/15:0cycw5)
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/14:0/14:0):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/14:0/16:0):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/14:0/18:1(9Z)):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:0/14:0):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:0/17:0cycw7):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:0/18:1(9Z)):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:0/19:0cycw7):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:1(9Z)):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/18:1(9Z)):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/17:0cycw7/16:0):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/17:0cycw7/17:0cycw7):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/17:0cycw7/18:1(9Z)):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/14:0):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:0):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:1(9Z)):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/17:0cycw7):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z)):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/19:0cycw7):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/19:0cycw7/16:0):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/19:0cycw7/18:1(9Z)):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:0/18:1(9Z)/19:0cycw7/19:0cycw7):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:0/18:1(9Z))
- Phospholipid Biosynthesis CL(16:1(9Z)/16:0/16:0/18:1(9Z)):
CDP-DG(16:1(9Z)/16:0) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(16:1(9Z)/16:0)
- Phospholipid Biosynthesis CL(18:1(9Z)/15:0cycw5/16:0/18:1(9Z)):
CDP-DG(18:1(9Z)/15:0cycw5) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(18:1(9Z)/15:0cycw5)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
文献列表
- Konstantina Karathanou, Ana-Nicoleta Bondar. Algorithm to catalogue topologies of dynamic lipid hydrogen-bond networks.
Biochimica et biophysica acta. Biomembranes.
2022 04; 1864(4):183859. doi:
10.1016/j.bbamem.2022.183859
. [PMID: 34999081] - Evgeniy Salnikov, Christopher Aisenbrey, Burkhard Bechinger. Lipid saturation and head group composition have a pronounced influence on the membrane insertion equilibrium of amphipathic helical polypeptides.
Biochimica et biophysica acta. Biomembranes.
2022 04; 1864(4):183844. doi:
10.1016/j.bbamem.2021.183844
. [PMID: 34954200] - Sandra Rocha, Ranjeet Kumar, Bengt Nordén, Pernilla Wittung-Stafshede. Orientation of α-Synuclein at Negatively Charged Lipid Vesicles: Linear Dichroism Reveals Time-Dependent Changes in Helix Binding Mode.
Journal of the American Chemical Society.
2021 11; 143(45):18899-18906. doi:
10.1021/jacs.1c05344
. [PMID: 34748321] - Amélie Bacle, Pavel Buslaev, Rebeca Garcia-Fandino, Fernando Favela-Rosales, Tiago Mendes Ferreira, Patrick F J Fuchs, Ivan Gushchin, Matti Javanainen, Anne M Kiirikki, Jesper J Madsen, Josef Melcr, Paula Milán Rodríguez, Markus S Miettinen, O H Samuli Ollila, Chris G Papadopoulos, Antonio Peón, Thomas J Piggot, Ángel Piñeiro, Salla I Virtanen. Inverse Conformational Selection in Lipid-Protein Binding.
Journal of the American Chemical Society.
2021 09; 143(34):13701-13709. doi:
10.1021/jacs.1c05549
. [PMID: 34465095] - Anna Chmielińska, Piotr Stepien, Piotr Bonarek, Mykhailo Girych, Giray Enkavi, Tomasz Rog, Marta Dziedzicka-Wasylewska, Agnieszka Polit. Can di-4-ANEPPDHQ reveal the structural differences between nanodiscs and liposomes?.
Biochimica et biophysica acta. Biomembranes.
2021 09; 1863(9):183649. doi:
10.1016/j.bbamem.2021.183649
. [PMID: 33991503] - Irina Oganesyan, Cristina Lento, Anurag Tandon, Derek J Wilson. Conformational Dynamics of α-Synuclein during the Interaction with Phospholipid Nanodiscs by Millisecond Hydrogen-Deuterium Exchange Mass Spectrometry.
Journal of the American Society for Mass Spectrometry.
2021 May; 32(5):1169-1179. doi:
10.1021/jasms.0c00463
. [PMID: 33784451] - Julija Mezhyrova, Janosch Martin, Oliver Peetz, Volker Dötsch, Nina Morgner, Yi Ma, Frank Bernhard. Membrane insertion mechanism and molecular assembly of the bacteriophage lysis toxin ΦX174-E.
The FEBS journal.
2021 05; 288(10):3300-3316. doi:
10.1111/febs.15642
. [PMID: 33244868] - Filomena Battista, Rosario Oliva, Pompea Del Vecchio, Roland Winter, Luigi Petraccone. Insights into the Action Mechanism of the Antimicrobial Peptide Lasioglossin III.
International journal of molecular sciences.
2021 Mar; 22(6):. doi:
10.3390/ijms22062857
. [PMID: 33799744] - Giuseppe Caruso, Claudia G Fresta, Angelita Costantino, Giacomo Lazzarino, Angela M Amorini, Giuseppe Lazzarino, Barbara Tavazzi, Susan M Lunte, Prajnaparamita Dhar, Massimo Gulisano, Filippo Caraci. Lung Surfactant Decreases Biochemical Alterations and Oxidative Stress Induced by a Sub-Toxic Concentration of Carbon Nanoparticles in Alveolar Epithelial and Microglial Cells.
International journal of molecular sciences.
2021 Mar; 22(5):. doi:
10.3390/ijms22052694
. [PMID: 33800016] - Samantha Schrecke, Yun Zhu, Jacob W McCabe, Mariah Bartz, Charles Packianathan, Minglei Zhao, Ming Zhou, David Russell, Arthur Laganowsky. Selective regulation of human TRAAK channels by biologically active phospholipids.
Nature chemical biology.
2021 01; 17(1):89-95. doi:
10.1038/s41589-020-00659-5
. [PMID: 32989299] - P Gehan, S Kulifaj, P Soule, J B Bodin, M Amoura, A Walrant, S Sagan, A R Thiam, K Ngo, V Vivier, S Cribier, N Rodriguez. Penetratin translocation mechanism through asymmetric droplet interface bilayers.
Biochimica et biophysica acta. Biomembranes.
2020 11; 1862(11):183415. doi:
10.1016/j.bbamem.2020.183415
. [PMID: 32710854] - Gagandeep Sandhu, Michael R Morrow, Valerie Booth. Roles of histidine charge and cardiolipin in membrane disruption by antimicrobial peptides Gaduscidin-1 and Gaduscidin-2.
Biochimica et biophysica acta. Biomembranes.
2020 11; 1862(11):183444. doi:
10.1016/j.bbamem.2020.183444
. [PMID: 32822647] - Mehdi Azouz, Alexandre Therrien, Corinne Buré, Caroline Tokarski, Sophie Lecomte, Michel Lafleur. Lipid selectivity in detergent extraction from bilayers.
Biochemical and biophysical research communications.
2020 10; 531(2):140-143. doi:
10.1016/j.bbrc.2020.07.065
. [PMID: 32782150] - Luís Henrique de Oliveira Almeida, Caio Fernando Ramalho de Oliveira, Mayara de Souza Rodrigues, Simone Maria Neto, Ana Paula de Araújo Boleti, Gabriel Bonan Taveira, Érica de Oliveira Mello, Valdirene Moreira Gomes, Edson Lucas Dos Santos, Edson Crusca, Octávio Luiz Franco, Marlon Henrique E Silva Cardoso, Maria Lígia Rodrigues Macedo. Adepamycin: design, synthesis and biological properties of a new peptide with antimicrobial properties.
Archives of biochemistry and biophysics.
2020 09; 691(?):108487. doi:
10.1016/j.abb.2020.108487
. [PMID: 32710881] - Christopher Aisenbrey, Mariana Amaro, Petr Pospíšil, Martin Hof, Burkhard Bechinger. Highly synergistic antimicrobial activity of magainin 2 and PGLa peptides is rooted in the formation of supramolecular complexes with lipids.
Scientific reports.
2020 07; 10(1):11652. doi:
10.1038/s41598-020-68416-1
. [PMID: 32669585] - Simli Dey, Anirban Das, Arpan Dey, Sudipta Maiti. Membrane affinity of individual toxic protein oligomers determined at the single-molecule level.
Physical chemistry chemical physics : PCCP.
2020 Jul; 22(26):14613-14620. doi:
10.1039/d0cp00450b
. [PMID: 32483579] - Irina Panina, Nikolay Krylov, Dmitry Nolde, Roman Efremov, Anton Chugunov. Environmental and dynamic effects explain how nisin captures membrane-bound lipid II.
Scientific reports.
2020 06; 10(1):8821. doi:
10.1038/s41598-020-65522-y
. [PMID: 32483218] - Asya Tsanova, Vishnya Stoyanova, Albena Jordanova, Ivo Grabchev. Study of the Mechanism of the Antimicrobial Activity of Novel Water Soluble Ammonium Quaternary Benzanthrone on Model Membranes.
The Journal of membrane biology.
2020 06; 253(3):247-256. doi:
10.1007/s00232-020-00121-6
. [PMID: 32393995] - Reza Amani, Collin G Borcik, Nazmul H Khan, Derek B Versteeg, Maryam Yekefallah, Hoa Q Do, Heather R Coats, Benjamin J Wylie. Conformational changes upon gating of KirBac1.1 into an open-activated state revealed by solid-state NMR and functional assays.
Proceedings of the National Academy of Sciences of the United States of America.
2020 02; 117(6):2938-2947. doi:
10.1073/pnas.1915010117
. [PMID: 31980523] - Karishma Bhasne, Neha Jain, Rishabh Karnawat, Shruti Arya, Anupa Majumdar, Anubhuti Singh, Samrat Mukhopadhyay. Discerning Dynamic Signatures of Membrane-Bound α-Synuclein Using Site-Specific Fluorescence Depolarization Kinetics.
The journal of physical chemistry. B.
2020 02; 124(5):708-717. doi:
10.1021/acs.jpcb.9b09118
. [PMID: 31917569] - Mercedes Echaide, Chiara Autilio, Elena López-Rodríguez, Antonio Cruz, Jesús Pérez-Gil. In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition.
Scientific reports.
2020 Jan; 10(1):1385. doi:
10.1038/s41598-020-58248-4
. [PMID: 31992800] - Bozena Augustyn, Piotr Stepien, Chetan Poojari, Edouard Mobarak, Agnieszka Polit, Anna Wisniewska-Becker, Tomasz Róg. Cholesteryl Hemisuccinate Is Not a Good Replacement for Cholesterol in Lipid Nanodiscs.
The journal of physical chemistry. B.
2019 11; 123(46):9839-9845. doi:
10.1021/acs.jpcb.9b07853
. [PMID: 31674185] - Ailing Tong, John T Petroff, Fong-Fu Hsu, Philipp Am Schmidpeter, Crina M Nimigean, Liam Sharp, Grace Brannigan, Wayland Wl Cheng. Direct binding of phosphatidylglycerol at specific sites modulates desensitization of a ligand-gated ion channel.
eLife.
2019 11; 8(?):. doi:
10.7554/elife.50766
. [PMID: 31724949] - Mohammad A Fallah, Karin Hauser. Immobilization approaches can affect protein dynamics: a surface-enhanced infrared spectroscopic study on lipid-protein interactions.
Biomaterials science.
2019 Aug; 7(8):3204-3212. doi:
10.1039/c9bm00140a
. [PMID: 31147655] - Kristy S McKeating, Samuel S Hinman, Nor Akmaliza Rais, Zhiguo Zhou, Quan Cheng. Antifouling Lipid Membranes over Protein A for Orientation-Controlled Immunosensing in Undiluted Serum and Plasma.
ACS sensors.
2019 07; 4(7):1774-1782. doi:
10.1021/acssensors.9b00257
. [PMID: 31262175] - Jingjing Guo, James C S Ho, Hokyun Chin, Alan E Mark, Cheng Zhou, Staffan Kjelleberg, Bo Liedberg, Atul N Parikh, Nam-Joon Cho, Jamie Hinks, Yuguang Mu, Thomas Seviour. Response of microbial membranes to butanol: interdigitation vs. disorder.
Physical chemistry chemical physics : PCCP.
2019 Jun; 21(22):11903-11915. doi:
10.1039/c9cp01469a
. [PMID: 31125035] - Gunjan Dixit, Indra D Sahu, Warren D Reynolds, Tessa M Wadsworth, Benjamin D Harding, Colleen K Jaycox, Carole Dabney-Smith, Charles R Sanders, Gary A Lorigan. Probing the Dynamics and Structural Topology of the Reconstituted Human KCNQ1 Voltage Sensor Domain (Q1-VSD) in Lipid Bilayers Using Electron Paramagnetic Resonance Spectroscopy.
Biochemistry.
2019 02; 58(7):965-973. doi:
10.1021/acs.biochem.8b01042
. [PMID: 30620191] - Gaëtan Dias Mirandela, Giulia Tamburrino, Paul A Hoskisson, Ulrich Zachariae, Arnaud Javelle. The lipid environment determines the activity of the Escherichia coli ammonium transporter AmtB.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
2019 02; 33(2):1989-1999. doi:
10.1096/fj.201800782r
. [PMID: 30211659] - James E Keener, Dane Evan Zambrano, Guozhi Zhang, Ciara K Zak, Deseree J Reid, Bhushan S Deodhar, Jeanne E Pemberton, James S Prell, Michael T Marty. Chemical Additives Enable Native Mass Spectrometry Measurement of Membrane Protein Oligomeric State within Intact Nanodiscs.
Journal of the American Chemical Society.
2019 01; 141(2):1054-1061. doi:
10.1021/jacs.8b11529
. [PMID: 30586296] - Rafael B Lira, Tom Robinson, Rumiana Dimova, Karin A Riske. Highly Efficient Protein-free Membrane Fusion: A Giant Vesicle Study.
Biophysical journal.
2019 01; 116(1):79-91. doi:
10.1016/j.bpj.2018.11.3128
. [PMID: 30579564] - Karolina Połeć, Beata Barnaś, Magdalena Kowalska, Michał Dymek, Rafał Rachwalik, Elżbieta Sikora, Artur Biela, Michał Kobiałka, Kinga Wójcik, Katarzyna Hąc-Wydro. The influence of the essential oil extracted from hops on monolayers and bilayers imitating plant pathogen bacteria membranes.
Colloids and surfaces. B, Biointerfaces.
2019 Jan; 173(?):672-680. doi:
10.1016/j.colsurfb.2018.10.047
. [PMID: 30384263] - Xue Kang, Christopher Elson, Jackson Penfield, Alex Kirui, Adrian Chen, Liqun Zhang, Tuo Wang. Integrated solid-state NMR and molecular dynamics modeling determines membrane insertion of human β-defensin analog.
Communications biology.
2019; 2(?):402. doi:
10.1038/s42003-019-0653-6
. [PMID: 31701030] - Alberto Ceccon, G Marius Clore, Vitali Tugarinov. Decorrelating Kinetic and Relaxation Parameters in Exchange Saturation Transfer NMR: A Case Study of N-Terminal Huntingtin Peptides Binding to Unilamellar Lipid Vesicles.
The journal of physical chemistry. B.
2018 12; 122(49):11271-11278. doi:
10.1021/acs.jpcb.8b07112
. [PMID: 30156416] - Seonghoon Kim, Marcos M Pires, Wonpil Im. Insight into Elongation Stages of Peptidoglycan Processing in Bacterial Cytoplasmic Membranes.
Scientific reports.
2018 12; 8(1):17704. doi:
10.1038/s41598-018-36075-y
. [PMID: 30531805] - Yunhan Zhang, Tongwei Chen, Zhimeng Pan, Xianbao Sun, Xue Yin, Miao He, Shiyan Xiao, Haojun Liang. Theoretical Insights into the Interactions between Star-Shaped Antimicrobial Polypeptides and Bacterial Membranes.
Langmuir : the ACS journal of surfaces and colloids.
2018 11; 34(44):13438-13448. doi:
10.1021/acs.langmuir.8b02677
. [PMID: 30350688] - Dayane S Alvares, Taisa G Viegas, João Ruggiero Neto. The effect of pH on the lytic activity of a synthetic mastoparan-like peptide in anionic model membranes.
Chemistry and physics of lipids.
2018 11; 216(?):54-64. doi:
10.1016/j.chemphyslip.2018.09.005
. [PMID: 30253128] - Antje Pokorny, Tala O Khatib, Heather Stevenson. A Quantitative Model of Daptomycin Binding to Lipid Bilayers.
The journal of physical chemistry. B.
2018 10; 122(39):9137-9146. doi:
10.1021/acs.jpcb.8b07503
. [PMID: 30247034] - Li-Juan Wang, Xiao-Dan Gu, Guo-Hua Yu, Liang Shen, Hong-Fang Ji. Different effects of lipid on conformational conversion of chicken and murine prion proteins.
Veterinary microbiology.
2018 Oct; 224(?):1-7. doi:
10.1016/j.vetmic.2018.08.018
. [PMID: 30269782] - Simou Sun, Anne M Sendecki, Saranya Pullanchery, Da Huang, Tinglu Yang, Paul S Cremer. Multistep Interactions between Ibuprofen and Lipid Membranes.
Langmuir : the ACS journal of surfaces and colloids.
2018 09; 34(36):10782-10792. doi:
10.1021/acs.langmuir.8b01878
. [PMID: 30148644] - Zhao Zhao, Meng Zhang, James M Hogle, William M Shih, Gerhard Wagner, Mahmoud L Nasr. DNA-Corralled Nanodiscs for the Structural and Functional Characterization of Membrane Proteins and Viral Entry.
Journal of the American Chemical Society.
2018 08; 140(34):10639-10643. doi:
10.1021/jacs.8b04638
. [PMID: 30094995] - G E Balatti, M F Martini, M Pickholz. A coarse-grained approach to studying the interactions of the antimicrobial peptides aurein 1.2 and maculatin 1.1 with POPG/POPE lipid mixtures.
Journal of molecular modeling.
2018 Jul; 24(8):208. doi:
10.1007/s00894-018-3747-z
. [PMID: 30019106] - Bappaditya Chandra, Barun Kumar Maity, Anirban Das, Sudipta Maiti. Fluorescence quenching by lipid encased nanoparticles shows that amyloid-β has a preferred orientation in the membrane.
Chemical communications (Cambridge, England).
2018 Jul; 54(56):7750-7753. doi:
10.1039/c8cc02108b
. [PMID: 29854995] - Idlir Liko, Matteo T Degiacomi, Sejeong Lee, Thomas D Newport, Joseph Gault, Eamonn Reading, Jonathan T S Hopper, Nicholas G Housden, Paul White, Matthew Colledge, Altin Sula, B A Wallace, Colin Kleanthous, Phillip J Stansfeld, Hagan Bayley, Justin L P Benesch, Timothy M Allison, Carol V Robinson. Lipid binding attenuates channel closure of the outer membrane protein OmpF.
Proceedings of the National Academy of Sciences of the United States of America.
2018 06; 115(26):6691-6696. doi:
10.1073/pnas.1721152115
. [PMID: 29891712] - José-Luis Velasco-Bolom, Gerardo Corzo, Ramón Garduño-Juárez. Molecular dynamics simulation of the membrane binding and disruption mechanisms by antimicrobial scorpion venom-derived peptides.
Journal of biomolecular structure & dynamics.
2018 Jun; 36(8):2070-2084. doi:
10.1080/07391102.2017.1341340
. [PMID: 28604248] - Takumi Furusato, Fumihiro Horie, Hideaki T Matsubayashi, Kazuaki Amikura, Yutetsu Kuruma, Takuya Ueda. De Novo Synthesis of Basal Bacterial Cell Division Proteins FtsZ, FtsA, and ZipA Inside Giant Vesicles.
ACS synthetic biology.
2018 04; 7(4):953-961. doi:
10.1021/acssynbio.7b00350
. [PMID: 29510621] - Liling Zhao, Zanxia Cao, Yunqiang Bian, Guodong Hu, Jihua Wang, Yaoqi Zhou. Molecular Dynamics Simulations of Human Antimicrobial Peptide LL-37 in Model POPC and POPG Lipid Bilayers.
International journal of molecular sciences.
2018 Apr; 19(4):. doi:
10.3390/ijms19041186
. [PMID: 29652823] - Tânia Silva, Bárbara Claro, Bruno F B Silva, Nuno Vale, Paula Gomes, Maria Salomé Gomes, Sérgio S Funari, José Teixeira, Daniela Uhríková, Margarida Bastos. Unravelling a Mechanism of Action for a Cecropin A-Melittin Hybrid Antimicrobial Peptide: The Induced Formation of Multilamellar Lipid Stacks.
Langmuir : the ACS journal of surfaces and colloids.
2018 02; 34(5):2158-2170. doi:
10.1021/acs.langmuir.7b03639
. [PMID: 29304549] - Rikeshwer Prasad Dewangan, Gopal Singh Bisht, Vijay Pal Singh, Mohammad Shahar Yar, Santosh Pasha. Design and synthesis of cell selective α/β-diastereomeric peptidomimetic with potent in vivo antibacterial activity against methicillin resistant S. Aureus.
Bioorganic chemistry.
2018 02; 76(?):538-547. doi:
10.1016/j.bioorg.2017.12.020
. [PMID: 29310083] - Takeshi Sunami, Kunihiro Shimada, Gakushi Tsuji, Satoshi Fujii. Flow Cytometric Analysis To Evaluate Morphological Changes in Giant Liposomes As Observed in Electrofusion Experiments.
Langmuir : the ACS journal of surfaces and colloids.
2018 01; 34(1):88-96. doi:
10.1021/acs.langmuir.7b03317
. [PMID: 29215888] - Jitendriya Swain, Micheline El Khoury, Julie Kempf, Florian Briée, Patrick Van Der Smissen, Jean-Luc Décout, Marie-Paule Mingeot-Leclercq. Effect of cardiolipin on the antimicrobial activity of a new amphiphilic aminoglycoside derivative on Pseudomonas aeruginosa.
PloS one.
2018; 13(8):e0201752. doi:
10.1371/journal.pone.0201752
. [PMID: 30125281] - Maria Rosa Loffredo, Anirban Ghosh, Nicole Harmouche, Bruno Casciaro, Vincenzo Luca, Annalisa Bortolotti, Floriana Cappiello, Lorenzo Stella, Anirban Bhunia, Burkhard Bechinger, Maria Luisa Mangoni. Membrane perturbing activities and structural properties of the frog-skin derived peptide Esculentin-1a(1-21)NH2 and its Diastereomer Esc(1-21)-1c: Correlation with their antipseudomonal and cytotoxic activity.
Biochimica et biophysica acta. Biomembranes.
2017 Dec; 1859(12):2327-2339. doi:
10.1016/j.bbamem.2017.09.009
. [PMID: 28912103] - Philipp Mühlhäuser, Parvesh Wadhwani, Erik Strandberg, Jochen Bürck, Anne S Ulrich. Structure analysis of the membrane-bound dermcidin-derived peptide SSL-25 from human sweat.
Biochimica et biophysica acta. Biomembranes.
2017 Dec; 1859(12):2308-2318. doi:
10.1016/j.bbamem.2017.09.004
. [PMID: 28888369] - C Dal Mas, D A Pinheiro, J D Campeiro, B Mattei, V Oliveira, E B Oliveira, A Miranda, K R Perez, M A F Hayashi. Biophysical and biological properties of small linear peptides derived from crotamine, a cationic antimicrobial/antitumoral toxin with cell penetrating and cargo delivery abilities.
Biochimica et biophysica acta. Biomembranes.
2017 Dec; 1859(12):2340-2349. doi:
10.1016/j.bbamem.2017.09.006
. [PMID: 28888370] - D R Bakirova, D A Faizullin, Yu A Valiullina, V V Salnikov, Yu F Zuev. Effect of Lipid Surface Composition on the Formation and Structure of Fibrin Clots.
Bulletin of experimental biology and medicine.
2017 Oct; 163(6):722-725. doi:
10.1007/s10517-017-3889-5
. [PMID: 29063338] - Shruti Mukherjee, Rajiv K Kar, Ravi Prakash Reddy Nanga, Kamal H Mroue, Ayyalusamy Ramamoorthy, Anirban Bhunia. Accelerated molecular dynamics simulation analysis of MSI-594 in a lipid bilayer.
Physical chemistry chemical physics : PCCP.
2017 Jul; 19(29):19289-19299. doi:
10.1039/c7cp01941f
. [PMID: 28702543] - Piotr Skrobecki, Anna Chmielińska, Piotr Bonarek, Piotr Stepien, Anna Wisniewska-Becker, Marta Dziedzicka-Wasylewska, Agnieszka Polit. Sulpiride, Amisulpride, Thioridazine, and Olanzapine: Interaction with Model Membranes. Thermodynamic and Structural Aspects.
ACS chemical neuroscience.
2017 07; 8(7):1543-1553. doi:
10.1021/acschemneuro.7b00057
. [PMID: 28375612] - Maria A Soria, Silvia A Cervantes, Thalia H Bajakian, Ansgar B Siemer. The Functional Amyloid Orb2A Binds to Lipid Membranes.
Biophysical journal.
2017 Jul; 113(1):37-47. doi:
10.1016/j.bpj.2017.05.039
. [PMID: 28700922] - Jumin Lee, Zhenning Ren, Ming Zhou, Wonpil Im. Molecular Simulation and Biochemical Studies Support an Elevator-type Transport Mechanism in EIIC.
Biophysical journal.
2017 Jun; 112(11):2249-2252. doi:
10.1016/j.bpj.2017.04.040
. [PMID: 28506526] - Ernanni D Vieira, Luis G M Basso, Antonio J Costa-Filho. Non-linear van't Hoff behavior in pulmonary surfactant model membranes.
Biochimica et biophysica acta. Biomembranes.
2017 Jun; 1859(6):1133-1143. doi:
10.1016/j.bbamem.2017.03.011
. [PMID: 28336314] - Alessandra Luchini, Yuri Gerelli, Giovanna Fragneto, Tommy Nylander, Gunnar K Pálsson, Marie-Sousai Appavou, Luigi Paduano. Neutron Reflectometry reveals the interaction between functionalized SPIONs and the surface of lipid bilayers.
Colloids and surfaces. B, Biointerfaces.
2017 Mar; 151(?):76-87. doi:
10.1016/j.colsurfb.2016.12.005
. [PMID: 27987458] - G K Varshney, S R Kintali, P K Gupta, K Das. A comparative study on the effect of Curcumin and Chlorin-p6 on the transport of the LDS cation across a negatively charged POPG bilayer: Effect of pH.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
2017 Feb; 173(?):132-138. doi:
10.1016/j.saa.2016.09.001
. [PMID: 27619975] - Jean-Pierre Duneau, Jonathan Khao, James N Sturgis. Lipid perturbation by membrane proteins and the lipophobic effect.
Biochimica et biophysica acta. Biomembranes.
2017 Jan; 1859(1):126-134. doi:
10.1016/j.bbamem.2016.10.014
. [PMID: 27794424] - Tsogbadrakh Mishig-Ochir, Davaadulam Gombosuren, Altanchimeg Jigjid, Badamkhatan Tuguldur, Galbadrakh Chuluunbaatar, Enerelt Urnukhsaikhan, Chinar Pathak, Bong-Jin Lee. Cellular Membrane Composition Requirement by Antimicrobial and Anticancer Peptide GA-K4.
Protein and peptide letters.
2017; 24(3):197-205. doi:
10.2174/0929866523666161216123509
. [PMID: 27993125] - Elisa La Bauve, Briana C Vernon, Dongmei Ye, David M Rogers, Cathryn M Siegrist, Bryan D Carson, Susan B Rempe, Aihua Zheng, Margaret Kielian, Andrew P Shreve, Michael S Kent. Method for measuring the unbinding energy of strongly-bound membrane-associated proteins.
Biochimica et biophysica acta.
2016 11; 1858(11):2753-2762. doi:
10.1016/j.bbamem.2016.07.004
. [PMID: 27425029] - Andrew F Craig, Emily E Clark, Indra D Sahu, Rongfu Zhang, Nick D Frantz, M Sameer Al-Abdul-Wahid, Carole Dabney-Smith, Dominik Konkolewicz, Gary A Lorigan. Tuning the size of styrene-maleic acid copolymer-lipid nanoparticles (SMALPs) using RAFT polymerization for biophysical studies.
Biochimica et biophysica acta.
2016 11; 1858(11):2931-2939. doi:
10.1016/j.bbamem.2016.08.004
. [PMID: 27539205] - G K Varshney, S R Kintali, P K Gupta, K Das. Effect of Bilayer Partitioning of Curcumin on the Adsorption and Transport of a Cationic Dye Across POPG Liposomes Probed by Second-Harmonic Spectroscopy.
Langmuir : the ACS journal of surfaces and colloids.
2016 10; 32(40):10415-10421. doi:
10.1021/acs.langmuir.6b02797
. [PMID: 27636651] - Kai Mihono, Takeshi Ohtsu, Mai Ohtani, Makoto Yoshimoto, Akio Kamimura. Modulation of cellulase activity by charged lipid bilayers with different acyl chain properties for efficient hydrolysis of ionic liquid-pretreated cellulose.
Colloids and surfaces. B, Biointerfaces.
2016 Oct; 146(?):198-203. doi:
10.1016/j.colsurfb.2016.06.005
. [PMID: 27318965] - B Scott Perrin, Riqiang Fu, Myriam L Cotten, Richard W Pastor. Simulations of Membrane-Disrupting Peptides II: AMP Piscidin 1 Favors Surface Defects over Pores.
Biophysical journal.
2016 Sep; 111(6):1258-1266. doi:
10.1016/j.bpj.2016.08.015
. [PMID: 27653484] - Weiying Zhu, Robert Silvers, Harald Schwalbe, Timothy A Keiderling. Reduced and mutant lysozyme refolding with lipid vesicles. Model study of disulfide impact on equilibria and dynamics.
Biochimica et biophysica acta.
2016 09; 1864(9):1083-1092. doi:
10.1016/j.bbapap.2016.05.010
. [PMID: 27240304] - Daniel J Hirst, Tzong-Hsien Lee, Ketav Kulkarni, Jacqueline A Wilce, Marie-Isabel Aguilar. The impact of cell-penetrating peptides on membrane bilayer structure during binding and insertion.
Biochimica et biophysica acta.
2016 08; 1858(8):1841-9. doi:
10.1016/j.bbamem.2016.05.004
. [PMID: 27163492] - Ludovico Migliolo, Mário R Felício, Marlon H Cardoso, Osmar N Silva, Mary-Ann E Xavier, Diego O Nolasco, Adeliana Silva de Oliveira, Ignasi Roca-Subira, Jordi Vila Estape, Leandro D Teixeira, Sonia M Freitas, Anselmo J Otero-Gonzalez, Sónia Gonçalves, Nuno C Santos, Octavio L Franco. Structural and functional evaluation of the palindromic alanine-rich antimicrobial peptide Pa-MAP2.
Biochimica et biophysica acta.
2016 Jul; 1858(7 Pt A):1488-98. doi:
10.1016/j.bbamem.2016.04.003
. [PMID: 27063608] - Kin Kuan Hoi, Carol V Robinson, Michael T Marty. Unraveling the Composition and Behavior of Heterogeneous Lipid Nanodiscs by Mass Spectrometry.
Analytical chemistry.
2016 06; 88(12):6199-204. doi:
10.1021/acs.analchem.6b00851
. [PMID: 27206251] - Pitchaimani Kandasamy, Mari Numata, Karin Zemski Berry, Rachel Fickes, Christina C Leslie, Robert C Murphy, Dennis R Voelker. Structural analogs of pulmonary surfactant phosphatidylglycerol inhibit toll-like receptor 2 and 4 signaling.
Journal of lipid research.
2016 06; 57(6):993-1005. doi:
10.1194/jlr.m065201
. [PMID: 27095543] - Natalie J Mitchell, Pamela Seaton, Antje Pokorny. Branched phospholipids render lipid vesicles more susceptible to membrane-active peptides.
Biochimica et biophysica acta.
2016 May; 1858(5):988-94. doi:
10.1016/j.bbamem.2015.10.014
. [PMID: 26514602] - Sung-Tae Yang, Volker Kiessling, Lukas K Tamm. Line tension at lipid phase boundaries as driving force for HIV fusion peptide-mediated fusion.
Nature communications.
2016 Apr; 7(?):11401. doi:
10.1038/ncomms11401
. [PMID: 27113279] - Kouki K Touhara, Weiwei Wang, Roderick MacKinnon. The GIRK1 subunit potentiates G protein activation of cardiac GIRK1/4 hetero-tetramers.
eLife.
2016 04; 5(?):. doi:
10.7554/elife.15750
. [PMID: 27074664] - Jordi H Borrell, M Teresa Montero, Antoni Morros, Òscar Domènech. Unspecific membrane protein-lipid recognition: combination of AFM imaging, force spectroscopy, DSC and FRET measurements.
Journal of molecular recognition : JMR.
2015 Nov; 28(11):679-86. doi:
10.1002/jmr.2483
. [PMID: 26046777] - Vicente Galiano, José Villalaín. Oleuropein aglycone in lipid bilayer membranes. A molecular dynamics study.
Biochimica et biophysica acta.
2015 Nov; 1848(11 Pt A):2849-58. doi:
10.1016/j.bbamem.2015.08.007
. [PMID: 26278640] - Patricia M Dijkman, Anthony Watts. Lipid modulation of early G protein-coupled receptor signalling events.
Biochimica et biophysica acta.
2015 Nov; 1848(11 Pt A):2889-97. doi:
10.1016/j.bbamem.2015.08.004
. [PMID: 26275588] - Joseph R Blasic, David L Worcester, Klaus Gawrisch, Philip Gurnev, Mihaela Mihailescu. Pore hydration states of KcsA potassium channels in membranes.
The Journal of biological chemistry.
2015 Oct; 290(44):26765-75. doi:
10.1074/jbc.m115.661819
. [PMID: 26370089] - Chris Neale, Henry D Herce, Régis Pomès, Angel E García. Can Specific Protein-Lipid Interactions Stabilize an Active State of the Beta 2 Adrenergic Receptor?.
Biophysical journal.
2015 Oct; 109(8):1652-62. doi:
10.1016/j.bpj.2015.08.028
. [PMID: 26488656] - Dejun Lin, Alan Grossfield. Thermodynamics of Micelle Formation and Membrane Fusion Modulate Antimicrobial Lipopeptide Activity.
Biophysical journal.
2015 Aug; 109(4):750-9. doi:
10.1016/j.bpj.2015.07.011
. [PMID: 26287627] - B Scott Perrin, Alexander J Sodt, Myriam L Cotten, Richard W Pastor. The Curvature Induction of Surface-Bound Antimicrobial Peptides Piscidin 1 and Piscidin 3 Varies with Lipid Chain Length.
The Journal of membrane biology.
2015 Jun; 248(3):455-67. doi:
10.1007/s00232-014-9733-1
. [PMID: 25292264] - Yuan Hu, Sandeep Patel. Structural and Thermodynamic Insight into Spontaneous Membrane-Translocating Peptides Across Model PC/PG Lipid Bilayers.
The Journal of membrane biology.
2015 Jun; 248(3):505-15. doi:
10.1007/s00232-014-9702-8
. [PMID: 25008278] - Cristina Olivieri, Francesco Buonocore, Simona Picchietti, Anna Rita Taddei, Chiara Bernini, Giuseppe Scapigliati, Alysha A Dicke, Vitaly V Vostrikov, Gianluigi Veglia, Fernando Porcelli. Structure and membrane interactions of chionodracine, a piscidin-like antimicrobial peptide from the icefish Chionodraco hamatus.
Biochimica et biophysica acta.
2015 Jun; 1848(6):1285-93. doi:
10.1016/j.bbamem.2015.02.030
. [PMID: 25749154] - Cong Guo, Sébastien Côté, Normand Mousseau, Guanghong Wei. Distinct helix propensities and membrane interactions of human and rat IAPP(1-19) monomers in anionic lipid bilayers.
The journal of physical chemistry. B.
2015 Feb; 119(8):3366-76. doi:
10.1021/jp5111357
. [PMID: 25646717] - Joseph C Fogarty, Mihir Arjunwadkar, Sagar A Pandit, Jianjun Pan. Atomically detailed lipid bilayer models for the interpretation of small angle neutron and X-ray scattering data.
Biochimica et biophysica acta.
2015 Feb; 1848(2):662-72. doi:
10.1016/j.bbamem.2014.10.041
. [PMID: 25448879] - Mariana Ferreira, Paula Gameiro. Ciprofloxacin metalloantibiotic: an effective antibiotic with an influx route strongly dependent on lipid interaction?.
The Journal of membrane biology.
2015 Feb; 248(1):125-36. doi:
10.1007/s00232-014-9749-6
. [PMID: 25378125] - Rosario Oliva, Pompea Del Vecchio, Marco Ignazio Stellato, Anna Maria D'Ursi, Gerardino D'Errico, Luigi Paduano, Luigi Petraccone. A thermodynamic signature of lipid segregation in biomembranes induced by a short peptide derived from glycoprotein gp36 of feline immunodeficiency virus.
Biochimica et biophysica acta.
2015 Feb; 1848(2):510-7. doi:
10.1016/j.bbamem.2014.10.017
. [PMID: 25450811] - R Galatola, A Cruz, M J Gómara, J Prat, M A Alsina, I Haro, M Pujol. Surface behavior of peptides from E1 GBV-C protein: Interaction with anionic model membranes and importance in HIV-1 FP inhibition.
Biochimica et biophysica acta.
2015 Feb; 1848(2):392-407. doi:
10.1016/j.bbamem.2014.10.033
. [PMID: 25450346] - Seung Won Shin, Kyung Soo Park, Min Su Jang, Woo Chul Song, Jin Kim, Seung-Woo Cho, Joo Young Lee, Jeong Ho Cho, Sunghwan Jung, Soong Ho Um. X-DNA origami-networked core-supported lipid stratum.
Langmuir : the ACS journal of surfaces and colloids.
2015 Jan; 31(3):912-6. doi:
10.1021/la503754e
. [PMID: 25585044] - Soichiro Tsuda, Tatsuya Sakakura, Satoshi Fujii, Hiroaki Suzuki, Tetsuya Yomo. Shape Transformations of Lipid Vesicles by Insertion of Bulky-Head Lipids.
PloS one.
2015; 10(7):e0132963. doi:
10.1371/journal.pone.0132963
. [PMID: 26176953] - Nuria Roldan, Erik Goormaghtigh, Jesús Pérez-Gil, Begoña Garcia-Alvarez. Palmitoylation as a key factor to modulate SP-C-lipid interactions in lung surfactant membrane multilayers.
Biochimica et biophysica acta.
2015 Jan; 1848(1 Pt A):184-91. doi:
10.1016/j.bbamem.2014.10.009
. [PMID: 25306965] - Rongfu Zhang, Indra D Sahu, Lishan Liu, Anna Osatuke, Raven G Comer, Carole Dabney-Smith, Gary A Lorigan. Characterizing the structure of lipodisq nanoparticles for membrane protein spectroscopic studies.
Biochimica et biophysica acta.
2015 Jan; 1848(1 Pt B):329-33. doi:
10.1016/j.bbamem.2014.05.008
. [PMID: 24853657] - Saurabh Srivastava, Ilia V Baskakov. Contrasting Effects of Two Lipid Cofactors of Prion Replication on the Conformation of the Prion Protein.
PloS one.
2015; 10(6):e0130283. doi:
10.1371/journal.pone.0130283
. [PMID: 26090881] - Laurie Bédard, Thierry Lefèvre, Émilie Morin-Michaud, Michèle Auger. Besides fibrillization: putative role of the peptide fragment 71-82 on the structural and assembly behavior of α-synuclein.
Biochemistry.
2014 Oct; 53(41):6463-72. doi:
10.1021/bi5008707
. [PMID: 25255476] - Chunkit Hong, D Peter Tieleman, Yi Wang. Microsecond molecular dynamics simulations of lipid mixing.
Langmuir : the ACS journal of surfaces and colloids.
2014 Oct; 30(40):11993-2001. doi:
10.1021/la502363b
. [PMID: 25237736] - Indra D Sahu, Brett M Kroncke, Rongfu Zhang, Megan M Dunagan, Hubbell J Smith, Andrew Craig, Robert M McCarrick, Charles R Sanders, Gary A Lorigan. Structural investigation of the transmembrane domain of KCNE1 in proteoliposomes.
Biochemistry.
2014 Oct; 53(40):6392-401. doi:
10.1021/bi500943p
. [PMID: 25234231] - Andrea Alessandrini, Paolo Facci. Phase transitions in supported lipid bilayers studied by AFM.
Soft matter.
2014 Oct; 10(37):7145-64. doi:
10.1039/c4sm01104j
. [PMID: 25090108]